Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres f...
Tencent has announced that the launch of an AI-supported auxiliary diagnostic system for conducting digital colposc...
Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China's prescriptio...
Alphamab Oncology, a leading biopharmaceutical company based in China dedicated to global development of innovative biol...
Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's&...
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...
Xinjun He, Ph.D., the executive director of Nanjing YiGenCloud Institute, a leading medical big data AI company in...
GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the pre...
Following 111, Inc.'s strategic partnership with Manulife-Sinochem last year, the Company has reached another miles...
New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Info...
Tencent announces the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Glo...
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotech...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
New research by Queen’s University Belfast has found that offering glaucoma screening in China could be highly cos...
A leading biopharmaceutical company in China, Mabpharm Limited has announced that the proposed listing of its ...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...
China Pharma Holdings, an NYSE American-listed corporation with a fully-integrated speciality pharmaceuticals subsi...
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...
Covestro is attending the China International Medical Equipment Fair (CMEF) spring show - the leading event in Chin...
TRIGR Therapeutics, Inc. ("TRIGR"), a clinical stage biotechnology company focused on the development of multi-targeted ...
MGI, a subsidiary of BGI Group, has disclosed that its first round of fundraising exceeded US$200 million, the...
Masimo and Shenzhen Mindray Bio-Medical Electronics Co., Ltd have entered into a new purchase and license agreement. The...
TAKE2 HEALTH LTD., a healthcare technology company based in Hong Kong, China, has entered into a definitive license agre...
Ally Bridge Group ("ABG"), a leading global life science investment group, announced that it led an over-subscribed ...
Artificial intelligence (AI) is pioneering a new wave of innovation in the medical industry prompting large healthcare p...
